Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2025-04-22 00:00:00 ET · period of report 2025-04-17 · accession 0001641172-25-005606 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-22 | 2025-04-17 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $8.98 | +5,400 | 5.57M | +0.1% | +$48.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-17 | P | A | 5,400 | $8.98 | 5,567,002 | D | — | — |